0125 GMT - Sigma Healthcare gets a new bear at Jefferies as its merger with privately owned Chemist Warehouse moves slowly toward the finish line. Analyst David Stanton tells clients in a note that, following the latest update from Australia's competition regulator, he now expects the merger to complete by the end of February. He had previously been eyeing the end of this month. Jefferies raises its fiscal 2025 forecasts for Chemist Warehouse sales and margins, supporting a 16% rise in its target price for Sigma shares to A$1.85. However, the stock's recent advance leads the investment bank to cut its recommendation to underperform from hold. Shares are down 1.95% at A$2.765. (stuart.condie@wsj.com)
(END) Dow Jones Newswires
December 11, 2024 20:25 ET (01:25 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。